Leaders of U.S. intelligence agencies on Thursday all endorsed the withdrawal of a 2025 intelligence report doubting a foreign role in so-called Havana Syndrome ...

Weekly injectable buprenorphine is more effective than daily doses for treating opioid use disorder in pregnancy, with higher ...

A new review shows insufficient or low-quality evidence to suggest cannabinoids are effective at treating most psychiatric conditions and substance use disorders.

Numerous studies have been published on the comorbidities associated with adrenal-related disorders. However, several gaps remain. <br/><br/>In Addison's disease, characterized by decreased production ...

In a clinical trial supported by the National Institutes of Health (NIH), a research team found that administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder ...

Three new studies reveal surprising insights on GLP-1 weight loss drugs, opioid treatment in pregnancy, and the real science behind good luck.

There was some evidence that cannabinoids can reduce symptoms of cannabis use disorder, insomnia, tic or Tourette's syndrome, and autism spectrum disorder, but the quality of this evidence was ...

By Sriparna Roy March 16 (Reuters) - Cannabis-based medicines have shown little evidence of effectiveness for treating most ...

After years of hiding his substance abuse, Ken Rideout finally confessed to his wife. It was the start of a difficult and rewarding journey, which led to athletic success in his 50s ...

A Spokane nonprofit that helps infants born in substance withdrawal is celebrating after the Legislature last week approved $2 million in funding for the facility. The money will ...

Researchers link glymphatic system (brain waste-clearance) dysfunction in childhood to the future development of psychosis and chemical imbalances.

A young dad said he has been "left screaming in agony" and "lost three years of his life" after suffering an horrific ...